Evangeline Watson

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape”.

Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape

eLife(2024)10.7554/elife.95952

N/A

0.406DataRank · unranked

10 citations

Surojit Sur, Laura Dobbyn, Evangeline Watson, Joshua D. Cohen, Blair Ptak +12 more

ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1

eLife(2024)10.7554/elife.94488

N/A

0.111DataRank · unranked

1 citations

Marco Dal Molin, Brian J. Mog, Gyuri Han, Evangeline Watson, Nicolas Wyhs +12 more

ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.07.23.550207

N/A

0DataRank · unranked

1 citations

Marco Dal Molin, Brian J. Mog, Gyuri Han, Evangeline Watson, Nicolas Wyhs +12 more

TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers

Nature(2024)10.1038/s41586-024-07233-2

N/A

0DataRank · unranked

44 citations

Jiaxin Ge, Brian J. Mog, Bum Seok Lee, Alexander H. Pearlman, Michael S. Hwang +22 more

Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities

Science Translational Medicine(2024)10.1126/scitranslmed.adg7123

N/A

0DataRank · unranked

25 citations

Nikita Marcou, Sarah R. DiNapoli, Alexander H. Pearlman, Tushar D. Nichakawade, Michael S. Hwang +19 more

ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1

eLife(2024)10.7554/elife.94488.1

N/A

0DataRank · unranked

0 citations

Marco Dal Molin, Brian J. Mog, Gyuri Han, Evangeline Watson, Nicolas Wyhs +12 more

Reviewer #2 (Public review): ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1

(2024)10.7554/elife.94488.2.sa1

N/A

0DataRank · unranked

0 citations

Marco Dal Molin, Brian Mog, Gyuri Han, Evangeline Watson, Nicolas Wyhs +12 more

TRBC2-targeting antibody–drug conjugates for the treatment of T cell cancers

Nature Cancer(2025)10.1038/s43018-025-01069-z

N/A

0DataRank · unranked

2 citations

Joshua Urban, Sarah R. DiNapoli, Bum Seok Lee, Taha Ahmedna, Tushar D. Nichakawade +26 more

Targeting a neoantigen derived from a common TP53 mutation

Science(2021)10.1126/science.abc8697

N/A

0DataRank · unranked

350 citations

Katharine M. Wright, Jacqueline Douglass, Michael S. Hwang, Brian J. Mog, Alexander H. Pearlman +20 more

ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1

eLife(2025)10.7554/elife.94488.3

N/A

0DataRank · unranked

0 citations

Marco Dal Molin, Brian J. Mog, Gyuri Han, Evangeline Watson, Nicolas Wyhs +12 more

Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.28.573594

N/A

0DataRank · unranked

4 citations

Surojit Sur, Laura Dobbyn, Evangeline Watson, Joshua D. Cohen, Blair Ptak +12 more